Microbot Medical
MBOT
68 hedge funds and large institutions have $27.4M invested in Microbot Medical in 2025 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 21 increasing their positions, 3 reducing their positions, and 9 closing their positions.
600% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 3
200% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 9
147% more capital invested
Capital invested by funds: $11.1M → $27.4M (+$16.3M)
138% more call options, than puts
Call options by funds: $4.12M | Put options by funds: $1.73M
36% more funds holding
Funds holding: 50 → 68 (+18)
4.92% more ownership
Funds ownership: 12.06% → 16.98% (+4.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.8M |
| 2 |
HCM
Heights Capital Management
San Francisco,
California
|
+$2.75M |
| 3 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$2.63M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$914K |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$647K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$468K |
| 2 |
Goldman Sachs
New York
|
-$85.7K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$43.3K |
| 4 |
Citigroup
New York
|
-$35.4K |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$32K |
MBOT Hedge Fund Activity: Q3 2025 in Review
68 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2025, worth a combined $27.4M — up 147% from $11.1M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new MBOT positions and 9 closed out — a net gain of 18 holders — while 21 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $3.8M. The largest seller was Morgan Stanley, cutting an estimated $468K.
- 68 institutional investors held Microbot Medical (MBOT) as of Q3 2025, up from 50 in Q2 2025.
- Funds reported $27.4M of Microbot Medical stock for Q3 2025, up 147% quarter-over-quarter.
- 27 funds opened new Microbot Medical positions in Q3 2025 and 9 closed out, a net change of +18 holders.
- The largest Microbot Medical buyer in Q3 2025 was Susquehanna International Group, an estimated $3.8M added.
- The largest Microbot Medical seller in Q3 2025 was Morgan Stanley, an estimated $468K sold.
Based on aggregated 13F filings for Q3 2025.